Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

Many cancer types — breast, prostate, skin cancer — have 5-year survival rates and ample treatment options if caught early.

Since 2023, the U.S. Food and Drug Administration (FDA) has not required animal testing, thanks in part to organoids, which ...

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in colorectal cancer.

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...

Marshall emphasizes the complexity of staying updated with various cancers and treatments, the diverse knowledge bases among ...

A new study, with help from artificial intelligence, focuses on reprogramming cancer stem cells and triggering some to ...

Exercise may significantly reduce the risk of colon cancer returning in patients after treatment, a new study has found. The late-phase trial, published Sunday in the New England Journal of Medicine ...

A new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights major gaps in the treatment experiences of people with metastatic colorectal ...

In a promising step that could change the future of cancer treatment, a research team from the University of Texas at Austin ...